You are viewing the site in preview mode

Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis

Fig. 3

Impact of non-pharmaceutical interventions on the monthly incidence of lower respiratory tract infections: A with ICU admission (N = 36,948) and B without ICU admission (N = 634,375) for children aged < 18 years from January 2015 to March 2023 in France. Incidence is expressed as the number of hospitalisations per 100,000 children per month. The black line shows the observed data. The blue line shows the model estimates based on observed data using the quasi-Poisson regression. The dashed red line shows the expected values assuming the NPI were not implemented using the same quasi-Poisson model. The blue and red shading indicates the 95% confidence intervals. Vertical dashed lines indicate NPI implementation and lifting. Pre-NPI period: 1 January 2015 to 31 March 2020. NPI period: 1 April 2020 to 31 March 2021. NPI-lifting period: 1 April 2021 to 31 March 2023. Abbreviations: ICU, intensive care unit; NPI, non-pharmaceutical intervention; LRTI, lower respiratory tract infection

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us